Abstract

New cis-platin analogs PdII and PtII complexes of (1H-benzimidazol-2-ylmethyl)-N-(4-chloro-phenyl)-amine (LCl) and (1H-benzimidazol-2-ylmethyl)-N-(4-iodo-phenyl)-amine (LI) were prepared as potential antitumor compounds, characterized (elemental analysis, TG/DTA, FT IR, 1H NMR, MS, UV–Vis. and conductance measurements) and tested for their cytotoxic activities against MCF7, HCT and HEPG2. The antibacterial activity was tested on against Staphylococcus aureus, Bacillus subtilis, Streptococcus faecalis, Escherichia coli, Pseudomonas aeruginosa and Neisseria gonorrhea. The effect of the aniline substituent on the toxicity was discussed. The experimental studies were complemented by quantum chemical calculations. TD-DFT calculations were carried out to understand the electronic structure and to explain the related experimental findings. Natural bond orbital analysis was performed to provide details about the electronic arrangement, type of hybridization and the nature of bonding.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.